Sophie Lucas (UCLouvain de Duve Institute) and her team succeeded in neutralising a molecule that blocks the immune system against cancer.
UCLouvain scientists discovered that this new immunotherapy increases the action of another well-known but not always effective immunotherapy, and that it makes tumour regression possible
This very promising discovery in the fight against cancer is published in the prestigious scientific journal Nature Communications
uclouvain.be/en/discover/pr...
The Nature Communications link has not yet been activated at the time of making this post.